PB2452
-
Investors Bullish on Malvern-Based PhaseBio as Its Stock Nearly Triples in Six Months
PhaseBio, a small biopharmaceuticals firm in Malvern, has seen its stock nearly triple in the last six months following its IPO, writes Joseph DiStefano for…
Pioneer Partner
Founding Partners
Advertisement
Affiliate Partners
Community Partners
